RIS Rx

RIS Rx operates as a healthcare technology company focused on optimizing pharmaceutical manufacturers' gross-to-net (GTN) revenue by addressing inefficiencies in patient affordability programs. Founded in 2020 by pharmacists Gerard Rivera and Stephen Hom, the company was established based on their direct experience with the complexities of drug dispensing and patient assistance. Their background in clinical pharmacy and pharmacology spurred the development of software solutions aimed at improving operational efficiencies and patient outcomes.

The company's business model centers on providing a technology platform to life sciences companies and pharmaceutical service organizations. This platform is engineered to identify and reduce revenue leakage from misdirected affordability programs, a market problem estimated at $90 billion annually in the U.S. RIS Rx generates revenue by offering its software solutions to a client base that includes over 23 manufacturers and more than 160 drug brands. The firm received a significant, undisclosed amount in a growth investment from Summit Partners in June 2025 to accelerate product development and team expansion.

RIS Rx's service portfolio is designed to tackle specific vulnerabilities within patient support operations. Key products include the 'Benefit Patient Solution (BPS),' which provides real-time identification and response to copay diversion schemes. Another offering, 'Affordability, Audit & Assurance (Triple A),' uses data-driven alerts to detect and intervene in pharmacy-level fraud and claims discrepancies. Additionally, 'Patient Guard 360 (PG360)' monitors charitable patient assistance programs to identify ineligible enrollees and guide them to appropriate support channels. These solutions leverage a proprietary technology and real-time analytics engine to deliver measurable savings for pharmaceutical clients without impeding patient access to treatments.

Keywords: gross-to-net, GTN optimization, pharmaceutical revenue leakage, patient affordability programs, copay diversion, healthcare technology, patient access services, pharmaceutical financial solutions, drug affordability, pharmacy benefit management, claims auditing, patient assistance programs, life sciences, healthcare analytics, Gerard Rivera, Stephen Hom, Summit Partners, revenue cycle management, pharma services, prescription access